trending Market Intelligence /marketintelligence/en/news-insights/trending/biveyu4ttd8cwbafwfmr5w2 content esgSubNav
In This List

DelMar Pharmaceuticals permanently appoints CEO

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


DelMar Pharmaceuticals permanently appoints CEO

Canada's DelMar Pharmaceuticals Inc. appointed Saiid Zarrabian as the full-time president and CEO of the company.

Zarrabian had been serving as the company's interim president and CEO since November 2017.

DelMar Pharmaceuticals develops therapies for treating cancer.